Scanship Holding ASA has through its subsidiary Scanship AS entered into a contract with STX France for delivery of its environmental technology to the world's largest cruise ship, the 5th RCCL Oasis-class vessel. This mega ship will be delivered to the market in 2021 having the capacity to carry more than 9000 people onboard. Scanship will deliver its advanced wastewater purification system and sludge treatment to ensure full compliance with the most strict discharge regulations to date. The contract is the third in line for the world largest cruise ship series and the 19th newbuild contract awarded Scanship by the French yard. "With this contract, we are continuing our strong leading market position in the Cruise industry, where Scanship AWP for clean oceans are being equipped on more than every second cruise ship entering service from 2014" says Scanship's CEO Henrik Badin in statement. For further queries, please contact: Henrik Badin - CEO Scanship Holding ASA Tel: + 47 90 78 98 25 Email: henrik.badin@scanship.no ABOUT SCANSHIP HOLDING ASA Scanship is a cruise industry leader in advanced technologies for clean oceans. Owners of vessels operating our systems have the solutions to convert all waste and wastewater to inert materials, recyclables, clean flue gas and effluent, which meets the highest international discharge standards. Our wastewater purification system is the only system in operation for large cruise ships which complies with the new effluent discharge standards for nutrient removal being enforced from 2019. Our new technologies will recover energy from waste and produce energy, providing tangible payback from the operations. We strive for the highest quality, innovation and sustainable solutions. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Scanship Holding ASA : Scanship awarded another worlds
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Zenas BioPharma Investors Urged to Join Class Action Lawsuit
Overview of the Class Action Lawsuit Levi & Korsinsky, LLP is reaching out to investors in Zenas BioPharma, Inc. regarding a crucial class action lawsuit. This lawsuit may greatly impact those who have invested in Zenas BioPharma as it seeks to compensate individuals who have suffered losses due to alleged securities fraud. Understanding the Legal Landscape This class...
Continue Reading
Ayar Labs Raises $155 Million to Transform AI Infrastructure
Ayar Labs Secures Significant Funding to Enhance AI Infrastructure Ayar Labs has recently secured $155 million in financing aimed at addressing the critical needs in AI infrastructure. With backing from prominent investors such as AMD Ventures, Intel Capital, and NVIDIA, alongside Advent Global Opportunities and Light Street Capital, this investment elevates the total...
Continue Reading
Transforming the Non-Profit Sector: The Impact Collaborative
Impact Collaborative Launches to Transform the Non-Profit Sector Today marks a significant milestone with the launch of the Impact Collaborative (IC), a pioneering initiative aimed at revolutionizing the support provided to under-resourced communities. This innovative approach seeks to disrupt generational poverty while offering much-needed access to mental health and...
Continue Reading
Synovus Financial Corp Declares Quarterly Dividends for Investors
Synovus Financial Corp Declares Quarterly Dividends Synovus Financial Corp. (NYSE: SNV) has recently revealed the details of its latest quarterly dividends. The board of directors has approved significant payouts to its shareholders, reinforcing the company’s ongoing commitment to deliver value to its investors. Details of the Declared Dividends The following dividends...
Continue Reading
Walnut Hill Medical Enhances Patient Access Through FDA TAP Program
Walnut Hill Medical Partners with FDA in TAP Program Walnut Hill Medical, a prominent healthcare consultancy known for its market access and reimbursement strategies, has been chosen as an advisor to the FDA's Total Product Life Cycle Advisory Program (TAP). This initiative, which originated from the FDA's Center for Devices and Radiological Health (CDRH), aims to improve...
Continue Reading